During the past decade, ATTIKON University Hospital conducted 113 clinical trials. In the 10-year time frame, 113 clinical trials started and 17 clinical trials were completed, i.e. on average, 15% percent of trials that started reached the finish line to date. In the past 5 years, 69 clinical trials started and 12 clinical trials were completed. i.e. 17.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ATTIKON University Hospital" #1 sponsor was "Attikon Hospital" with 21 trials, followed by "University of Athens" with 19 trials sponsored, "Amgen" with 10 trials sponsored, "Hoffmann-La Roche" with 8 trials sponsored and "Boehringer Ingelheim" with 8 trials sponsored. Other sponsors include 68 different institutions and companies that sponsored additional 57 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ATTIKON University Hospital" #1 collaborator was "Attikon Hospital" with 3 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "NEAT - European AIDS Treatment Network" with 2 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator and "Takeda Development Center Americas, Inc." with 2 trials as a collaborator. Other collaborators include 53 different institutions and companies that were collaborators in the rest 62 trials.

According to Clinical.Site data, the most researched conditions in "ATTIKON University Hospital" are "Coronary Artery Disease" (5 trials), "Psoriasis" (4 trials), "Pulmonary Arterial Hypertension" (4 trials), "Atrial Fibrillation" (3 trials) and "COVID-19" (3 trials). Many other conditions were trialed in "ATTIKON University Hospital" in a lesser frequency.

Most popular intervention types in "ATTIKON University Hospital" are "Drug" (83 trials), "Other" (20 trials), "Device" (11 trials), "Diagnostic Test" (8 trials) and "Procedure" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (31 trials), "Apremilast" (3 trials), "Cisplatin" (3 trials), "Soticlestat" (3 trials) and "Atezolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "ATTIKON University Hospital" are 134 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are 57 active trials in "ATTIKON University Hospital". 1 are not yet recruiting, 38 are recruiting, 17 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 52 completed trials in ATTIKON University Hospital, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in ATTIKON University Hospital, 2 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 47 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 23 trials that are defined as “Not Applicable".